user: aaavl2821

3002 karma | created 8 years ago

biopharma and healthcare baybridgebio.com

richard at baybridgebio.com

recent submissions

Sophistical Refutations (en.wikipedia.org)

1 pts|5 months ago|discuss

Sophist (en.wikipedia.org)

15 pts|5 months ago|5 comments

Can AI predict clinical trial outcomes? (baybridgebio.com)

2 pts|8 months ago|discuss

AI won't replace biotech analysts (baybridgebio.com)

1 pts|8 months ago|discuss

Show HN: Research Pharma Markets with AI (baybridgebio.com)

2 pts|11 months ago|discuss

1 pts|1 year ago|discuss

Better obesity drugs are coming soon (baybridgebio.com)

2 pts|1 year ago|discuss

The Future of the Obesity Market (baybridgebio.com)

1 pts|1 year ago|discuss

The obesity drug landscape in one chart (baybridgebio.com)

3 pts|1 year ago|discuss

A primer on the obesity drug landscape (baybridgebio.com)

2 pts|1 year ago|discuss

AI-enabled biotech startup analysis (baybridgebio.com)

1 pts|2 years ago|discuss

Analyzing gene therapy startup in layman's terms (baybridgebio.com)

1 pts|2 years ago|discuss

AI Analysis of Biotech Startups (baybridgebio.com)

2 pts|2 years ago|discuss

1 pts|2 years ago|discuss

Quantifying risk / reward in biotech investing (baybridgebio.com)

1 pts|2 years ago|discuss

Valuing Biotech Licensing Deals (baybridgebio.com)

1 pts|2 years ago|discuss

Show HN: Value Biotech Licensing Deals (baybridgebio.com)

2 pts|2 years ago|discuss

Which VCs are still investing in biopharma? (baybridgebio.com)

1 pts|2 years ago|discuss

Biotech VC on pace for worst year since 2016 (baybridgebio.com)

2 pts|2 years ago|discuss

The biotech venture capital crunch (baybridgebio.com)

1 pts|2 years ago|discuss